Stay updated on mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial.

Sign up to get notified when there's something new on the mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial. page.
Latest website image capture
Clouds background image

Latest updates to the mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial. page

  1. Check
    3 days ago
    Change Detected
    Summary
    Removed the small related-topics section for “Melanoma” (including “MedlinePlus Genetics”) from the page.
    Difference
    0.1%
    Check dated 2026-04-23T15:26:44.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added and Revision: v3.5.0 was removed.
    Difference
    0.0%
    Check dated 2026-04-16T11:09:20.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    Revision metadata updated to v3.5.0, replacing the previous v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-18T18:06:04.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Added Melanoma and related topics, including MedlinePlus Genetics, to the page's related resources. Updated the revision note to Revision: v3.4.3 and removed the previous Revision: v3.4.2.
    Difference
    0.2%
    Check dated 2026-03-11T16:46:43.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    - Removal of key topic keywords 'Melanoma' and the related topics section 'MedlinePlus Genetics' from the page content. This affects how the study's scope is communicated and indexed.
    Difference
    0.1%
    Check dated 2026-03-04T12:24:38.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    - Added Related Topics: Melanoma and MedlinePlus Genetics to the study page to provide supplementary background resources. This does not modify core study content.
    Difference
    0.1%
    Check dated 2026-02-25T08:44:56.000Z thumbnail image

Stay in the know with updates to mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial.

Enter your email address, and we'll notify you when there's something new on the mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial. page.